Electrophysiologic properties of perhexiline

Area of Science:

• Cardiovascular Pharmacology
• Electrophysiology

Background:

• Perhexiline maleate is a potential antiarrhythmic and antianginal medication.
• Understanding its electrophysiologic effects is crucial for clinical application.

Purpose of the Study:

• To evaluate the electrophysiologic effects of perhexiline maleate on the canine heart's conduction system.
• To determine safety and potential toxicity across therapeutic and toxic doses.

Main Methods:

• Intracardiac conduction times were measured using electrodes in anesthetized dogs.
• Perhexiline maleate was administered intravenously in incremental doses.
• Control animals received the maleate diluent.
• Effects on stimulation thresholds, intervals (QRS, QT), sinus rate, and rhythm were recorded.

Main Results:

• Perhexiline maleate did not significantly alter sinus rate, QT interval, QRS duration, PR interval, or conduction times (atrial, AV nodal, His-Purkinje).
• The drug did not affect cardiac electrical stimulation thresholds below 0.1 mA.
• No ectopic atrial or ventricular activity was observed.

Conclusions:

• Perhexiline maleate demonstrates a lack of deleterious effects on the intact canine heart's conduction system.
• The drug exhibits negligible toxicity and efficacy in treating ventricular tachyarrhythmias.
• Further clinical evaluation of perhexiline maleate is warranted.